MedTech News
![](https://startllc.com/wp-content/uploads/2024/06/4WEB_Medical_CSTS-300x240.jpg)
4WEB Medical Announces Commercial Launch of its Cervical Spine Integrated Plating Solution
DALLAS, June 19, 2024 /PRNewswire/ — 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology™, announced the initial launch of the newest addition to the company’s portfolio, the Cervical Spine Truss System Integrated Plating Solution (CSTS-IPS). The first procedures were performed by Kris Parchuri, DO, orthopedic spine surgeon at Spine & Orthopedic Specialists in Tulsa, OK and Jason Alder, MD, Director of Spinal Surgery at Baylor Scott & White Medical Center in Frisco, TX.
![](https://startllc.com/wp-content/uploads/2024/06/MTI-Website-69-300x174.jpg)
Elixir Medical’s coronary bioadaptor system granted FDA breakthrough device designation
The designation recognises the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease.
![](https://startllc.com/wp-content/uploads/2024/06/VitaFlow_Liberty__Transcatheter_Aortic_Valve_and_Retrievable_Delivery_System-300x170.jpg)
CardioFlow’s VitaFlow Liberty™ Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap
SHANGHAI, June 17, 2024 /PRNewswire/ — MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the VitaFlow LibertyTM Transcatheter Aortic Valve and Retrievable Delivery System (VitaFlow LibertyTM), has received EU CE-MDR certification. This certification highlights VitaFlow LibertyTM as a pioneering TAVI solution, that sets a new benchmark in transcatheter heart valve treatments.
![](https://startllc.com/wp-content/uploads/2024/06/Physicians-using-Philips-Zenition-90-Mobile-C-arm-300x195-1.jpg)
Philips wins FDA nod for new mobile C-arm
Philips (NYSE:PHG) announced today that it launched its now FDA-cleared Zenition 90 motorized mobile C-arm system.
![](https://startllc.com/wp-content/uploads/2024/06/MIT_Leuko-Labs-01_0-300x200.jpg)
A new way to spot life-threatening infections in cancer patients
Leuko, founded by a research team at MIT, is giving doctors a noninvasive way to monitor cancer patients’ health during chemotherapy — no blood tests needed.
![](https://startllc.com/wp-content/uploads/2024/06/venus-300x149.jpg)
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
This marks a significant advancement in the international progress of VenusP-Valve and represents another milestone following its CE MDR approval in April 2022.
![](https://startllc.com/wp-content/uploads/2024/06/Xeltis-receives-IDE-approval-from-FDA-for-aXess™-trial-300x162.jpg)
Xeltis receives IDE approval from FDA for initiation of US pivotal trial for aXess™, its restorative vascular access conduit
aXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, permanent, living vessel
![](https://startllc.com/wp-content/uploads/2024/06/MKT_PMT_631_Rev_0___Graphic___Press_Release___CORUS_Navigation_Access_System_CISION-300x169.jpg)
Providence Medical Technology, Inc. Announces FDA Clearance of CORUS™ Navigation Access System for Use with Medtronic’s StealthStation™ Surgical Navigation in Posterior Spinal Fusion
The potential benefits of utilizing the CORUS™ Navigation Access System to perform a navigated CORUS fusion include:
> Enhanced accuracy and precision with surgical instruments and spinal implants, e.g., CAVUX FFS-LX.
> Improved visualization of the facet joints and other anatomical structures during procedures.
> Reduced risk of complications and shorter operative time.